Form D — Aer Therapeutics, Inc.
0001998609-25-000004 · filed Feb 7, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $5,000,000
- Reported amount sold
- $5,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Aer Therapeutics, Inc.
- CIK
- 1959576
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 8 Davis Dr
Research Triangle Park, North Carolina 27709 - Phone
- 213-247-8328
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
THOMAS MATHERS · Executive OfficerRALEIGH, North Carolina Find on LinkedIn ↗
-
JOHN FAHY · DirectorRALEIGH, North Carolina Find on LinkedIn ↗
-
RISHI GUPTA · DirectorRALEIGH, North Carolina Find on LinkedIn ↗
-
TIM SHANNON · DirectorRALEIGH, North Carolina Find on LinkedIn ↗
-
CHRISTY SHAFFER · DirectorRALEIGH, North Carolina Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗